<?xml version="1.0" encoding="UTF-8"?>
<p>Efficacy (i.e., duration of severe neutropenia) was evaluated through CBCs with differential performed pretreatment and on Days 1, 2, and 3 of every cycle. For patients with an ANC ≥1.5 × 10
 <sup>9</sup>/L on Day 3, subsequent CBCs were performed twice weekly. If at any time ANC was &lt;1.5 × 10
 <sup>9</sup>/L, daily CBCs were performed until ANC recovered to ≥1.5 × 10
 <sup>9</sup>/L.
</p>
